A novel candidate for immunologic target in treatment of multiple myeloma.

被引：0
|
作者：
Matsushita, Maiko [1 ]
Saito, Saku [1 ]
Mori, Kanae [1 ]
Yokoe, Shinya [1 ]
Ichikawa, Daiju [1 ]
Hattori, Yutaka [1 ]
机构：
[1] Keio Univ, Fac Pharm, Tokyo, Japan
来源：
CANCER IMMUNOLOGY RESEARCH | 2020年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B73
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [21] Identification of novel caspase substrates expressed in multiple myeloma.
    Ghias, K
    Krett, NL
    Cryns, VL
    Rosen, ST
    BLOOD, 2002, 100 (11) : 808A - 808A
  • [22] Ropporin is a novel cancer testis antigen for multiple myeloma.
    Chiriva-Internati, M.
    Ferrari, R.
    Kelly, A.
    Yuefei, Y.
    Cobos, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S302 - S302
  • [23] A case of multiple myeloma.
    McConnell, G
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1923, 165 : 184 - 195
  • [24] TRACP-5b: A novel marker for monitoring bisphosphonates treatment in multiple myeloma.
    Terpos, E
    de la Fuente, J
    Viniou, N
    Meletis, J
    Papaioannou, M
    Yataganas, X
    Goldman, JM
    Rahemtulla, A
    BLOOD, 2002, 100 (11) : 811A - 811A
  • [25] NSC 338258 represents a novel anti-neoplastic agent for the treatment of multiple myeloma.
    Tian, Erming
    Landowski, Terry
    Stephens, Owen
    Yaccoby, Shmuel
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    BLOOD, 2006, 108 (11) : 989A - 990A
  • [26] CZDez: An oral chemotherapeutic regimen for the treatment of multiple myeloma.
    Moreton, P
    Morgan, GJ
    Cooke, G
    Hillmen, P
    Child, T
    BLOOD, 2001, 98 (11) : 310B - 310B
  • [27] Plasmapheresis in the treatment of renal failure associated with multiple myeloma.
    Kumar, Ambuj
    Djulbegovic, Benjamin
    Soares, Heloisa P.
    BLOOD, 2006, 108 (11) : 1024A - 1024A
  • [28] Unmutated incomplete DJH rearrangementes as a novel target for real-time PCR quantification in multiple myeloma.
    González, D
    González, M
    Alonso, ME
    López-Pérez, R
    Balanzategui, A
    Chillón, MC
    Silva, M
    García-Sanz, R
    San Miguel, JF
    BLOOD, 2002, 100 (11) : 371B - 371B
  • [29] p53-related protein kinase is a novel prognostic marker and therapeutic target in multiple myeloma.
    Cottini, Francesca
    Hideshima, Teru
    Nozawa, Yoshihisa
    Ohguchi, Hiroto
    Utsugi, Teruhiro
    Anderson, Kenneth C.
    CLINICAL CANCER RESEARCH, 2017, 23 (24) : 35 - 35
  • [30] Oncoprotein 18 (Op18) : A Differentially Expressed Gene Is a Novel Therapeutic Target in Multiple Myeloma.
    Pelluru, Dheeraj
    Wang, Jingyi
    Prabhala, Rao
    Fulciniti, Mariateresa
    Shammas, Masood A.
    Amin, Samirkumar B.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    BLOOD, 2008, 112 (11) : 947 - 947
12345